nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.0243	0.145	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.0238	0.142	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.0128	0.076	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.0125	0.0744	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.00733	0.0436	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.00719	0.0428	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.00717	0.0427	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.00703	0.0419	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.00281	0.0167	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.00275	0.0164	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—ITPR2—kidney cancer	0.00198	0.0118	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—ITPR2—kidney cancer	0.00194	0.0116	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.00177	0.0106	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.00174	0.0103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—ANXA1—kidney cancer	0.00166	0.0099	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—ANXA1—kidney cancer	0.00163	0.00969	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—OR4C13—kidney cancer	0.0016	0.00954	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—OR4C13—kidney cancer	0.00157	0.00934	CbGpPWpGaD
Carboprost Tromethamine—Tafluprost—PTGS2—kidney cancer	0.0015	1	CrCbGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.00149	0.00886	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Temsirolimus—kidney cancer	0.00147	0.00177	CcSEcCtD
Carboprost Tromethamine—Shock—Sorafenib—kidney cancer	0.00147	0.00177	CcSEcCtD
Carboprost Tromethamine—Rash—Temsirolimus—kidney cancer	0.00146	0.00175	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Temsirolimus—kidney cancer	0.00146	0.00175	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.00146	0.00867	CbGpPWpGaD
Carboprost Tromethamine—Chills—Gemcitabine—kidney cancer	0.00146	0.00175	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—OR4C13—kidney cancer	0.00145	0.00866	CbGpPWpGaD
Carboprost Tromethamine—Headache—Temsirolimus—kidney cancer	0.00145	0.00174	CcSEcCtD
Carboprost Tromethamine—Dizziness—Pazopanib—kidney cancer	0.00144	0.00173	CcSEcCtD
Carboprost Tromethamine—Back pain—Vincristine—kidney cancer	0.00144	0.00173	CcSEcCtD
Carboprost Tromethamine—Hiccups—Doxorubicin—kidney cancer	0.00143	0.00172	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Paclitaxel—kidney cancer	0.00143	0.00172	CcSEcCtD
Carboprost Tromethamine—Infection—Sunitinib—kidney cancer	0.00143	0.00172	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—OR4C13—kidney cancer	0.00142	0.00848	CbGpPWpGaD
Carboprost Tromethamine—Pain—Erlotinib—kidney cancer	0.00142	0.00171	CcSEcCtD
Carboprost Tromethamine—Myalgia—Dactinomycin—kidney cancer	0.00142	0.00171	CcSEcCtD
Carboprost Tromethamine—Shock—Sunitinib—kidney cancer	0.00141	0.0017	CcSEcCtD
Carboprost Tromethamine—Asthma—Capecitabine—kidney cancer	0.00139	0.00168	CcSEcCtD
Carboprost Tromethamine—Vomiting—Pazopanib—kidney cancer	0.00138	0.00167	CcSEcCtD
Carboprost Tromethamine—Rash—Pazopanib—kidney cancer	0.00137	0.00165	CcSEcCtD
Carboprost Tromethamine—Nausea—Temsirolimus—kidney cancer	0.00137	0.00165	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Pazopanib—kidney cancer	0.00137	0.00165	CcSEcCtD
Carboprost Tromethamine—Back pain—Gemcitabine—kidney cancer	0.00137	0.00164	CcSEcCtD
Carboprost Tromethamine—Headache—Pazopanib—kidney cancer	0.00136	0.00164	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00136	0.00164	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Everolimus—kidney cancer	0.00136	0.00164	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Capecitabine—kidney cancer	0.00136	0.00163	CcSEcCtD
Carboprost Tromethamine—Infection—Dactinomycin—kidney cancer	0.00135	0.00163	CcSEcCtD
Carboprost Tromethamine—Vertigo—Vincristine—kidney cancer	0.00134	0.00161	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Sorafenib—kidney cancer	0.00133	0.0016	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Doxorubicin—kidney cancer	0.00131	0.00158	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Erlotinib—kidney cancer	0.00131	0.00158	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00131	0.00158	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Capecitabine—kidney cancer	0.00129	0.00156	CcSEcCtD
Carboprost Tromethamine—Nausea—Pazopanib—kidney cancer	0.00129	0.00156	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Sunitinib—kidney cancer	0.00129	0.00155	CcSEcCtD
Carboprost Tromethamine—Hypertension—Vincristine—kidney cancer	0.00128	0.00155	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Sunitinib—kidney cancer	0.00128	0.00154	CcSEcCtD
Carboprost Tromethamine—Pain—Sorafenib—kidney cancer	0.00128	0.00154	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Doxorubicin—kidney cancer	0.00127	0.00153	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Vinblastine—kidney cancer	0.00127	0.00153	CcSEcCtD
Carboprost Tromethamine—Myalgia—Vincristine—kidney cancer	0.00127	0.00153	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Everolimus—kidney cancer	0.00127	0.00152	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Paclitaxel—kidney cancer	0.00127	0.00152	CcSEcCtD
Carboprost Tromethamine—Flushing—Paclitaxel—kidney cancer	0.00126	0.00152	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00124	0.00149	CcSEcCtD
Carboprost Tromethamine—Asthenia—Vinblastine—kidney cancer	0.00124	0.00149	CcSEcCtD
Carboprost Tromethamine—Asthenia—Everolimus—kidney cancer	0.00123	0.00149	CcSEcCtD
Carboprost Tromethamine—Cough—Gemcitabine—kidney cancer	0.00123	0.00148	CcSEcCtD
Carboprost Tromethamine—Pain—Sunitinib—kidney cancer	0.00123	0.00148	CcSEcCtD
Carboprost Tromethamine—Hypertension—Gemcitabine—kidney cancer	0.00122	0.00147	CcSEcCtD
Carboprost Tromethamine—Chills—Paclitaxel—kidney cancer	0.00122	0.00147	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Vincristine—kidney cancer	0.00121	0.00146	CcSEcCtD
Carboprost Tromethamine—Infection—Vincristine—kidney cancer	0.00121	0.00145	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Capecitabine—kidney cancer	0.00121	0.00145	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Doxorubicin—kidney cancer	0.00121	0.00145	CcSEcCtD
Carboprost Tromethamine—Chest pain—Gemcitabine—kidney cancer	0.0012	0.00145	CcSEcCtD
Carboprost Tromethamine—Myalgia—Gemcitabine—kidney cancer	0.0012	0.00145	CcSEcCtD
Carboprost Tromethamine—Asthenia—Erlotinib—kidney cancer	0.00119	0.00143	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Vinblastine—kidney cancer	0.00118	0.00142	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Sorafenib—kidney cancer	0.00118	0.00142	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Everolimus—kidney cancer	0.00118	0.00142	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Vincristine—kidney cancer	0.00117	0.00141	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Capecitabine—kidney cancer	0.00117	0.00141	CcSEcCtD
Carboprost Tromethamine—Pain—Dactinomycin—kidney cancer	0.00116	0.0014	CcSEcCtD
Carboprost Tromethamine—Tension—Paclitaxel—kidney cancer	0.00116	0.0014	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Gemcitabine—kidney cancer	0.00115	0.00139	CcSEcCtD
Carboprost Tromethamine—Eye pain—Doxorubicin—kidney cancer	0.00115	0.00138	CcSEcCtD
Carboprost Tromethamine—Nervousness—Paclitaxel—kidney cancer	0.00115	0.00138	CcSEcCtD
Carboprost Tromethamine—Infection—Gemcitabine—kidney cancer	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—Back pain—Paclitaxel—kidney cancer	0.00114	0.00138	CcSEcCtD
Carboprost Tromethamine—Dizziness—Vinblastine—kidney cancer	0.00114	0.00137	CcSEcCtD
Carboprost Tromethamine—Dizziness—Everolimus—kidney cancer	0.00114	0.00137	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Paclitaxel—kidney cancer	0.00114	0.00137	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Sunitinib—kidney cancer	0.00114	0.00137	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Erlotinib—kidney cancer	0.00113	0.00137	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Paclitaxel—kidney cancer	0.00111	0.00134	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00111	0.00134	CcSEcCtD
Carboprost Tromethamine—Hot flush—Doxorubicin—kidney cancer	0.00111	0.00134	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00111	0.00133	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.0011	0.00656	CbGpPWpGaD
Carboprost Tromethamine—Menopausal symptoms—Doxorubicin—kidney cancer	0.0011	0.00132	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Sorafenib—kidney cancer	0.0011	0.00132	CcSEcCtD
Carboprost Tromethamine—Vomiting—Vinblastine—kidney cancer	0.0011	0.00132	CcSEcCtD
Carboprost Tromethamine—Dizziness—Erlotinib—kidney cancer	0.0011	0.00132	CcSEcCtD
Carboprost Tromethamine—Vomiting—Everolimus—kidney cancer	0.00109	0.00132	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Vincristine—kidney cancer	0.00109	0.00131	CcSEcCtD
Carboprost Tromethamine—Rash—Everolimus—kidney cancer	0.00108	0.00131	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Everolimus—kidney cancer	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—Headache—Vinblastine—kidney cancer	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—Angioedema—Paclitaxel—kidney cancer	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00108	0.00642	CbGpPWpGaD
Carboprost Tromethamine—Headache—Everolimus—kidney cancer	0.00108	0.0013	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Dactinomycin—kidney cancer	0.00107	0.00129	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00107	0.00129	CcSEcCtD
Carboprost Tromethamine—Asthenia—Sorafenib—kidney cancer	0.00107	0.00129	CcSEcCtD
Carboprost Tromethamine—Vertigo—Paclitaxel—kidney cancer	0.00106	0.00128	CcSEcCtD
Carboprost Tromethamine—Syncope—Paclitaxel—kidney cancer	0.00106	0.00128	CcSEcCtD
Carboprost Tromethamine—Lethargy—Doxorubicin—kidney cancer	0.00106	0.00128	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Sunitinib—kidney cancer	0.00106	0.00127	CcSEcCtD
Carboprost Tromethamine—Vomiting—Erlotinib—kidney cancer	0.00105	0.00127	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00105	0.00126	CcSEcCtD
Carboprost Tromethamine—Rash—Erlotinib—kidney cancer	0.00105	0.00126	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Erlotinib—kidney cancer	0.00104	0.00126	CcSEcCtD
Carboprost Tromethamine—Palpitations—Paclitaxel—kidney cancer	0.00104	0.00126	CcSEcCtD
Carboprost Tromethamine—Headache—Erlotinib—kidney cancer	0.00104	0.00125	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Capecitabine—kidney cancer	0.00104	0.00125	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Paclitaxel—kidney cancer	0.00104	0.00125	CcSEcCtD
Carboprost Tromethamine—Pain—Vincristine—kidney cancer	0.00104	0.00125	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Gemcitabine—kidney cancer	0.00103	0.00125	CcSEcCtD
Carboprost Tromethamine—Flushing—Capecitabine—kidney cancer	0.00103	0.00125	CcSEcCtD
Carboprost Tromethamine—Cough—Paclitaxel—kidney cancer	0.00103	0.00124	CcSEcCtD
Carboprost Tromethamine—Asthenia—Sunitinib—kidney cancer	0.00103	0.00124	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Gemcitabine—kidney cancer	0.00103	0.00124	CcSEcCtD
Carboprost Tromethamine—Nausea—Vinblastine—kidney cancer	0.00103	0.00123	CcSEcCtD
Carboprost Tromethamine—Somnolence—Gemcitabine—kidney cancer	0.00102	0.00123	CcSEcCtD
Carboprost Tromethamine—Nausea—Everolimus—kidney cancer	0.00102	0.00123	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Sorafenib—kidney cancer	0.00102	0.00123	CcSEcCtD
Carboprost Tromethamine—Hypertension—Paclitaxel—kidney cancer	0.00102	0.00123	CcSEcCtD
Carboprost Tromethamine—Myalgia—Paclitaxel—kidney cancer	0.00101	0.00121	CcSEcCtD
Carboprost Tromethamine—Chest pain—Paclitaxel—kidney cancer	0.00101	0.00121	CcSEcCtD
Carboprost Tromethamine—Anxiety—Paclitaxel—kidney cancer	0.001	0.00121	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Dactinomycin—kidney cancer	0.001	0.00121	CcSEcCtD
Carboprost Tromethamine—Chills—Capecitabine—kidney cancer	0.001	0.0012	CcSEcCtD
Carboprost Tromethamine—Dizziness—Sorafenib—kidney cancer	0.000987	0.00119	CcSEcCtD
Carboprost Tromethamine—Pain—Gemcitabine—kidney cancer	0.000985	0.00119	CcSEcCtD
Carboprost Tromethamine—Nausea—Erlotinib—kidney cancer	0.000985	0.00119	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Sunitinib—kidney cancer	0.000982	0.00118	CcSEcCtD
Carboprost Tromethamine—Asthenia—Dactinomycin—kidney cancer	0.000975	0.00117	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000965	0.00116	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Vincristine—kidney cancer	0.00096	0.00116	CcSEcCtD
Carboprost Tromethamine—Infection—Paclitaxel—kidney cancer	0.000958	0.00115	CcSEcCtD
Carboprost Tromethamine—Dizziness—Sunitinib—kidney cancer	0.00095	0.00114	CcSEcCtD
Carboprost Tromethamine—Shock—Paclitaxel—kidney cancer	0.000949	0.00114	CcSEcCtD
Carboprost Tromethamine—Vomiting—Sorafenib—kidney cancer	0.000949	0.00114	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000948	0.00114	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Paclitaxel—kidney cancer	0.000941	0.00113	CcSEcCtD
Carboprost Tromethamine—Rash—Sorafenib—kidney cancer	0.000941	0.00113	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Sorafenib—kidney cancer	0.00094	0.00113	CcSEcCtD
Carboprost Tromethamine—Back pain—Capecitabine—kidney cancer	0.000938	0.00113	CcSEcCtD
Carboprost Tromethamine—Headache—Sorafenib—kidney cancer	0.000935	0.00113	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Capecitabine—kidney cancer	0.000933	0.00112	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000933	0.00112	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Dactinomycin—kidney cancer	0.00093	0.00112	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Capecitabine—kidney cancer	0.000914	0.0011	CcSEcCtD
Carboprost Tromethamine—Vomiting—Sunitinib—kidney cancer	0.000913	0.0011	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Gemcitabine—kidney cancer	0.000911	0.0011	CcSEcCtD
Carboprost Tromethamine—Rash—Sunitinib—kidney cancer	0.000905	0.00109	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Sunitinib—kidney cancer	0.000905	0.00109	CcSEcCtD
Carboprost Tromethamine—Headache—Sunitinib—kidney cancer	0.0009	0.00108	CcSEcCtD
Carboprost Tromethamine—Asthma—Doxorubicin—kidney cancer	0.000897	0.00108	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Vincristine—kidney cancer	0.000895	0.00108	CcSEcCtD
Carboprost Tromethamine—Nausea—Sorafenib—kidney cancer	0.000886	0.00107	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000879	0.00106	CcSEcCtD
Carboprost Tromethamine—Vertigo—Capecitabine—kidney cancer	0.000871	0.00105	CcSEcCtD
Carboprost Tromethamine—Asthenia—Vincristine—kidney cancer	0.000871	0.00105	CcSEcCtD
Carboprost Tromethamine—Syncope—Capecitabine—kidney cancer	0.00087	0.00105	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Paclitaxel—kidney cancer	0.000866	0.00104	CcSEcCtD
Carboprost Tromethamine—Vomiting—Dactinomycin—kidney cancer	0.000864	0.00104	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Paclitaxel—kidney cancer	0.00086	0.00104	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—OR4C13—kidney cancer	0.000859	0.00512	CbGpPWpGaD
Carboprost Tromethamine—Somnolence—Paclitaxel—kidney cancer	0.000858	0.00103	CcSEcCtD
Carboprost Tromethamine—Palpitations—Capecitabine—kidney cancer	0.000857	0.00103	CcSEcCtD
Carboprost Tromethamine—Rash—Dactinomycin—kidney cancer	0.000857	0.00103	CcSEcCtD
Carboprost Tromethamine—Nausea—Sunitinib—kidney cancer	0.000853	0.00103	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Capecitabine—kidney cancer	0.000853	0.00103	CcSEcCtD
Carboprost Tromethamine—Cough—Capecitabine—kidney cancer	0.000846	0.00102	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—OR4C13—kidney cancer	0.000841	0.00501	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ANXA1—kidney cancer	0.000838	0.00499	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Capecitabine—kidney cancer	0.000837	0.00101	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000834	0.001	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Vincristine—kidney cancer	0.000831	0.001	CcSEcCtD
Carboprost Tromethamine—Asthenia—Gemcitabine—kidney cancer	0.000827	0.000995	CcSEcCtD
Carboprost Tromethamine—Chest pain—Capecitabine—kidney cancer	0.000826	0.000994	CcSEcCtD
Carboprost Tromethamine—Myalgia—Capecitabine—kidney cancer	0.000826	0.000994	CcSEcCtD
Carboprost Tromethamine—Pain—Paclitaxel—kidney cancer	0.000825	0.000993	CcSEcCtD
Carboprost Tromethamine—Anxiety—Capecitabine—kidney cancer	0.000823	0.000991	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ANXA1—kidney cancer	0.000821	0.00489	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Dactinomycin—kidney cancer	0.000807	0.000972	CcSEcCtD
Carboprost Tromethamine—Dizziness—Vincristine—kidney cancer	0.000803	0.000967	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Doxorubicin—kidney cancer	0.0008	0.000963	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Gemcitabine—kidney cancer	0.000788	0.000949	CcSEcCtD
Carboprost Tromethamine—Infection—Capecitabine—kidney cancer	0.000786	0.000947	CcSEcCtD
Carboprost Tromethamine—Shock—Capecitabine—kidney cancer	0.000779	0.000938	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Doxorubicin—kidney cancer	0.000778	0.000936	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Capecitabine—kidney cancer	0.000773	0.00093	CcSEcCtD
Carboprost Tromethamine—Vomiting—Vincristine—kidney cancer	0.000772	0.00093	CcSEcCtD
Carboprost Tromethamine—Rash—Vincristine—kidney cancer	0.000766	0.000922	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Capecitabine—kidney cancer	0.000765	0.000921	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Vincristine—kidney cancer	0.000765	0.000921	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Paclitaxel—kidney cancer	0.000763	0.000918	CcSEcCtD
Carboprost Tromethamine—Headache—Vincristine—kidney cancer	0.000761	0.000916	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Doxorubicin—kidney cancer	0.000755	0.000909	CcSEcCtD
Carboprost Tromethamine—Vomiting—Gemcitabine—kidney cancer	0.000733	0.000882	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LATS1—kidney cancer	0.00073	0.00435	CbGpPWpGaD
Carboprost Tromethamine—Rash—Gemcitabine—kidney cancer	0.000726	0.000875	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Gemcitabine—kidney cancer	0.000726	0.000874	CcSEcCtD
Carboprost Tromethamine—Headache—Gemcitabine—kidney cancer	0.000722	0.000869	CcSEcCtD
Carboprost Tromethamine—Nausea—Vincristine—kidney cancer	0.000721	0.000869	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000721	0.000868	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LATS1—kidney cancer	0.000715	0.00426	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Capecitabine—kidney cancer	0.000711	0.000856	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Paclitaxel—kidney cancer	0.000711	0.000856	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Capecitabine—kidney cancer	0.000706	0.00085	CcSEcCtD
Carboprost Tromethamine—Asthenia—Paclitaxel—kidney cancer	0.000692	0.000833	CcSEcCtD
Carboprost Tromethamine—Nausea—Gemcitabine—kidney cancer	0.000684	0.000824	CcSEcCtD
Carboprost Tromethamine—Pain—Capecitabine—kidney cancer	0.000677	0.000815	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Doxorubicin—kidney cancer	0.00067	0.000806	CcSEcCtD
Carboprost Tromethamine—Flushing—Doxorubicin—kidney cancer	0.000667	0.000803	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKAP13—kidney cancer	0.000665	0.00396	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Paclitaxel—kidney cancer	0.00066	0.000795	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKAP13—kidney cancer	0.000651	0.00388	CbGpPWpGaD
Carboprost Tromethamine—Chills—Doxorubicin—kidney cancer	0.000644	0.000776	CcSEcCtD
Carboprost Tromethamine—Dizziness—Paclitaxel—kidney cancer	0.000638	0.000768	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Capecitabine—kidney cancer	0.000626	0.000753	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AMER1—kidney cancer	0.000621	0.0037	CbGpPWpGaD
Carboprost Tromethamine—Tension—Doxorubicin—kidney cancer	0.000614	0.000739	CcSEcCtD
Carboprost Tromethamine—Vomiting—Paclitaxel—kidney cancer	0.000613	0.000738	CcSEcCtD
Carboprost Tromethamine—Rash—Paclitaxel—kidney cancer	0.000608	0.000732	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AMER1—kidney cancer	0.000608	0.00362	CbGpPWpGaD
Carboprost Tromethamine—Dermatitis—Paclitaxel—kidney cancer	0.000608	0.000732	CcSEcCtD
Carboprost Tromethamine—Nervousness—Doxorubicin—kidney cancer	0.000607	0.000731	CcSEcCtD
Carboprost Tromethamine—Back pain—Doxorubicin—kidney cancer	0.000605	0.000728	CcSEcCtD
Carboprost Tromethamine—Headache—Paclitaxel—kidney cancer	0.000604	0.000728	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKAP13—kidney cancer	0.000604	0.0036	CbGpPWpGaD
Carboprost Tromethamine—Muscle spasms—Doxorubicin—kidney cancer	0.000601	0.000724	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000601	0.00358	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKAP13—kidney cancer	0.000591	0.00352	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Doxorubicin—kidney cancer	0.000589	0.000709	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000588	0.0035	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Capecitabine—kidney cancer	0.000583	0.000702	CcSEcCtD
Carboprost Tromethamine—Nausea—Paclitaxel—kidney cancer	0.000573	0.00069	CcSEcCtD
Carboprost Tromethamine—Asthenia—Capecitabine—kidney cancer	0.000568	0.000684	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ITPR2—kidney cancer	0.000565	0.00337	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Doxorubicin—kidney cancer	0.000562	0.000676	CcSEcCtD
Carboprost Tromethamine—Syncope—Doxorubicin—kidney cancer	0.000561	0.000675	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ITPR2—kidney cancer	0.000553	0.0033	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Doxorubicin—kidney cancer	0.000553	0.000665	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Doxorubicin—kidney cancer	0.00055	0.000662	CcSEcCtD
Carboprost Tromethamine—Cough—Doxorubicin—kidney cancer	0.000546	0.000657	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Capecitabine—kidney cancer	0.000542	0.000652	CcSEcCtD
Carboprost Tromethamine—Hypertension—Doxorubicin—kidney cancer	0.00054	0.00065	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000539	0.00321	CbGpPWpGaD
Carboprost Tromethamine—Chest pain—Doxorubicin—kidney cancer	0.000532	0.000641	CcSEcCtD
Carboprost Tromethamine—Myalgia—Doxorubicin—kidney cancer	0.000532	0.000641	CcSEcCtD
Carboprost Tromethamine—Anxiety—Doxorubicin—kidney cancer	0.00053	0.000639	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000528	0.00314	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Capecitabine—kidney cancer	0.000524	0.00063	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CER1—kidney cancer	0.00052	0.0031	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GPC3—kidney cancer	0.00052	0.0031	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ITPR2—kidney cancer	0.000513	0.00306	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Doxorubicin—kidney cancer	0.00051	0.000614	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CER1—kidney cancer	0.000509	0.00303	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GPC3—kidney cancer	0.000509	0.00303	CbGpPWpGaD
Carboprost Tromethamine—Infection—Doxorubicin—kidney cancer	0.000507	0.00061	CcSEcCtD
Carboprost Tromethamine—Vomiting—Capecitabine—kidney cancer	0.000503	0.000606	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ITPR2—kidney cancer	0.000503	0.00299	CbGpPWpGaD
Carboprost Tromethamine—Shock—Doxorubicin—kidney cancer	0.000502	0.000604	CcSEcCtD
Carboprost Tromethamine—Rash—Capecitabine—kidney cancer	0.000499	0.000601	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Capecitabine—kidney cancer	0.000499	0.0006	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Doxorubicin—kidney cancer	0.000498	0.0006	CcSEcCtD
Carboprost Tromethamine—Headache—Capecitabine—kidney cancer	0.000496	0.000597	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000493	0.000594	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ANXA1—kidney cancer	0.000474	0.00282	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Capecitabine—kidney cancer	0.00047	0.000566	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000465	0.00056	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ANXA1—kidney cancer	0.000464	0.00276	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Doxorubicin—kidney cancer	0.000458	0.000552	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Doxorubicin—kidney cancer	0.000455	0.000548	CcSEcCtD
Carboprost Tromethamine—Somnolence—Doxorubicin—kidney cancer	0.000454	0.000546	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SFRP2—kidney cancer	0.000443	0.00264	CbGpPWpGaD
Carboprost Tromethamine—Pain—Doxorubicin—kidney cancer	0.000436	0.000525	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SFRP2—kidney cancer	0.000433	0.00258	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000433	0.00258	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ANXA1—kidney cancer	0.00043	0.00256	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000424	0.00252	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ANXA1—kidney cancer	0.000421	0.00251	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000412	0.00245	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—POMC—kidney cancer	0.000411	0.00245	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Doxorubicin—kidney cancer	0.000403	0.000486	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000403	0.0024	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—POMC—kidney cancer	0.000402	0.00239	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—PIK3CA—kidney cancer	0.0004	0.00238	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000391	0.00233	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000389	0.00232	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000381	0.00227	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Doxorubicin—kidney cancer	0.000376	0.000453	CcSEcCtD
Carboprost Tromethamine—Asthenia—Doxorubicin—kidney cancer	0.000366	0.000441	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000357	0.00213	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CASP2—kidney cancer	0.000357	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKAP13—kidney cancer	0.000357	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.00035	0.00208	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKAP13—kidney cancer	0.000349	0.00208	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CASP2—kidney cancer	0.000349	0.00208	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Doxorubicin—kidney cancer	0.000349	0.00042	CcSEcCtD
Carboprost Tromethamine—Dizziness—Doxorubicin—kidney cancer	0.000337	0.000406	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GRB7—kidney cancer	0.000326	0.00194	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Doxorubicin—kidney cancer	0.000324	0.000391	CcSEcCtD
Carboprost Tromethamine—Rash—Doxorubicin—kidney cancer	0.000322	0.000387	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Doxorubicin—kidney cancer	0.000321	0.000387	CcSEcCtD
Carboprost Tromethamine—Headache—Doxorubicin—kidney cancer	0.00032	0.000385	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GRB7—kidney cancer	0.000319	0.0019	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ITPR2—kidney cancer	0.000303	0.00181	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Doxorubicin—kidney cancer	0.000303	0.000365	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ITPR2—kidney cancer	0.000297	0.00177	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CTNNA1—kidney cancer	0.000275	0.00164	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HSPB1—kidney cancer	0.000273	0.00163	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EIF4EBP1—kidney cancer	0.000273	0.00163	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CTNNA1—kidney cancer	0.000269	0.0016	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EIF4EBP1—kidney cancer	0.000268	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HSPB1—kidney cancer	0.000268	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TSC1—kidney cancer	0.000254	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PSMD7—kidney cancer	0.000254	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ANXA1—kidney cancer	0.000254	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PSMD7—kidney cancer	0.000249	0.00148	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TSC1—kidney cancer	0.000249	0.00148	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ANXA1—kidney cancer	0.000249	0.00148	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FLT1—kidney cancer	0.000246	0.00147	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FLT1—kidney cancer	0.000241	0.00144	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—POMC—kidney cancer	0.000232	0.00138	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PAK1—kidney cancer	0.000228	0.00136	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JUNB—kidney cancer	0.000228	0.00136	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—POMC—kidney cancer	0.000227	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JUNB—kidney cancer	0.000223	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PAK1—kidney cancer	0.000223	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—POMC—kidney cancer	0.000211	0.00126	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—POMC—kidney cancer	0.000206	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF2—kidney cancer	0.000187	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CDKN2B—kidney cancer	0.000186	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF2—kidney cancer	0.000183	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CDKN2B—kidney cancer	0.000182	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF1R—kidney cancer	0.00018	0.00107	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF1R—kidney cancer	0.000177	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RAF1—kidney cancer	0.000174	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—kidney cancer	0.000172	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RAF1—kidney cancer	0.00017	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—kidney cancer	0.000168	0.001	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL2—kidney cancer	0.000156	0.000928	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL2—kidney cancer	0.000153	0.000909	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HIF1A—kidney cancer	0.000148	0.000884	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TSC2—kidney cancer	0.000148	0.000882	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HIF1A—kidney cancer	0.000145	0.000866	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TSC2—kidney cancer	0.000145	0.000864	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KDR—kidney cancer	0.000142	0.000846	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KDR—kidney cancer	0.000139	0.000828	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APC—kidney cancer	0.000131	0.000779	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KIT—kidney cancer	0.000131	0.000779	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KIT—kidney cancer	0.000128	0.000763	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APC—kidney cancer	0.000128	0.000763	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MAPK3—kidney cancer	0.000125	0.000746	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—POMC—kidney cancer	0.000125	0.000742	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BRAF—kidney cancer	0.000123	0.000732	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MAPK3—kidney cancer	0.000123	0.00073	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—POMC—kidney cancer	0.000122	0.000726	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BRAF—kidney cancer	0.00012	0.000717	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MAPK1—kidney cancer	0.000119	0.00071	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MAPK1—kidney cancer	0.000117	0.000695	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—kidney cancer	0.000114	0.000678	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—kidney cancer	0.000113	0.000671	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—kidney cancer	0.000111	0.000664	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—kidney cancer	0.00011	0.000656	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—kidney cancer	0.000103	0.000616	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RAF1—kidney cancer	0.000103	0.000612	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RELA—kidney cancer	0.000102	0.000609	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—kidney cancer	0.000102	0.000605	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—kidney cancer	0.000101	0.000603	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RAF1—kidney cancer	0.0001	0.000599	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MTOR—kidney cancer	0.0001	0.000597	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RELA—kidney cancer	0.0001	0.000596	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—kidney cancer	9.94e-05	0.000592	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MTOR—kidney cancer	9.81e-05	0.000584	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CDKN1B—kidney cancer	9.41e-05	0.00056	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CDKN1B—kidney cancer	9.21e-05	0.000548	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL2—kidney cancer	9.21e-05	0.000548	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL2—kidney cancer	9.01e-05	0.000537	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCND1—kidney cancer	8.97e-05	0.000535	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JUN—kidney cancer	8.96e-05	0.000533	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CTNNB1—kidney cancer	8.89e-05	0.000529	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCND1—kidney cancer	8.78e-05	0.000523	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JUN—kidney cancer	8.77e-05	0.000522	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CTNNB1—kidney cancer	8.7e-05	0.000518	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTEN—kidney cancer	8.66e-05	0.000516	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTEN—kidney cancer	8.48e-05	0.000505	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—kidney cancer	7.82e-05	0.000466	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—kidney cancer	7.66e-05	0.000456	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK3—kidney cancer	7.4e-05	0.000441	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK3—kidney cancer	7.24e-05	0.000431	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—kidney cancer	7.2e-05	0.000429	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—kidney cancer	7.05e-05	0.00042	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK1—kidney cancer	7.04e-05	0.000419	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK1—kidney cancer	6.89e-05	0.000411	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KRAS—kidney cancer	6.65e-05	0.000396	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KRAS—kidney cancer	6.51e-05	0.000388	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—kidney cancer	6.11e-05	0.000364	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—kidney cancer	5.98e-05	0.000356	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—kidney cancer	5.91e-05	0.000352	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—kidney cancer	5.79e-05	0.000345	CbGpPWpGaD
